High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma

Cancer Medicine

Volumn 2, Issue 6, 2013, Pages 950-963

  Téllez Gabriel, Marta ^a,b   Arroyo Solera, Irene ^a,b   León, Xavier ^b,c   Gallardo, Alberto ^d   López, Montserrat ^c   Céspedes, Maria V ^a,b   Casanova, Isolda ^a,b   López Pousa, Antonio ^b,c   Quer, Miquel ^c   Mangues, Maria A ^c   Barnadas, Agustí ^c   Mangues, Ramón ^a,b   Pavón, Miguel A ^a,b  

^a BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HNSCC; PROGNOSIS; RAB25; TUMOR SUPPRESSOR;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AZACITIDINE; CARCINOMA, SQUAMOUS CELL; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CISPLATIN; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; PROGNOSIS; RAB GTP-BINDING PROTEINS; RNA, MESSENGER; TREATMENT OUTCOME;

EID: 84906923107     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.153     Document Type: Article

References (46)